Huahai Pharmaceutical: Minimal conversion of convertible bonds

Zhejiang Huahai Pharmaceutical (SSE:600521) announced that only CNY 182,000 of its "Huahai Convertible Bonds" have been converted into company shares as of June 30, 2025. This conversion resulted in 5,304 new shares, representing 0.00036% of the company's issued share capital before the conversion. The remaining outstanding amount of convertible bonds yet to be converted stands at CNY 1,842,417,000, accounting for 99.9901% of the total issued amount. There were no conversions during the recent quarter (April 1, 2025 - June 30, 2025). The company also noted that it had completed the cancellation of 10,656,753 repurchased shares on June 16, 2025, reducing its total share capital accordingly. The current conversion price is CNY 33.31 per share after adjustments made for dividend distributions and share repurchases. A further adjustment will be made in July 2025, bringing the price to CNY 33.06 per share.